December 25, 2024 11:39 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Man sets himself on fire near Parliament building; locals, police rush him to hospital | Azerbaijan Airlines passenger plane enroute to Russia with over 70 people onboard crashes in Kazakhstan | Atishi will be arrested in fake case, claims Arvind Kejriwal after Delhi govt disowns health and women's schemes | Delhi govt departments disown Arvind Kejriwal's major poll promises, AAP chief reacts | 'Our nation will always be grateful to him': PM Modi writes article in tribute to Atal Bihari Vajpayee on his birth centenary | Syria: Christmas tree set on fire by suspected 'Islamists', Christians protest | Pakistan strikes TTP camps in Afghanistan, Taliban government claims civilians killed | Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case
GVK BIO announces completion of drug repurposing efforts

GVK BIO announces completion of drug repurposing efforts

Oct 22, 2014, at 02:33 am

Kolkata, Oct 21 (IBNS): GVK Biosciences (GVK BIO), Asia's leading integrated Discovery Research and Development organization on Tuesday announced the successful completion of in-silico based alternative indications of shelved compounds for Takeda Pharmaceutical Company Limited using GVK BIO's proprietary Drug Repurposing Platform.